| Autor: |
Stridsman C; Dept of Public Health and Clinical Medicine, Division of Medicine/The OLIN-unit, Umeå University, Umeå, Sweden Caroline.stridsman@norrbotten.se., Vanfleteren LEGW; COPD Center, Dept of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden.; Dept of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Konradsen JR; Dept of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden., Axelsson Fisk S; Dept of Clinical Sciences Lund, Obstetrics and Gynaecology, Lund University and Ystad Hospital, Lund, Sweden., Pedroletti C; Dept of Women's and Children's Health, Uppsala University, Uppsala, Sweden., Sjöö Y; The Swedish National Airway Register, Gothenburg, Sweden., Syk J; Dept of Women's and Children's Health, Uppsala University, Uppsala, Sweden.; Academic Primary Health Care Centre, Stockholm, Sweden.; Dept of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden., Sterner T; Dept of Occupational and Environmental Dermatology, Skåne University Hospital, Lund University, Malmö, Sweden., Lindberg A; Dept of Public Health and Clinical Medicine, Division of Medicine/The OLIN-unit, Umeå University, Umeå, Sweden., Tunsäter A; Dept of Respiratory Medicine and Allergology, Skåne University Hospital, Lund University, Lund, Sweden., Nyberg F; School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Ekberg-Jansson A; Dept of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Karlsson Sundbaum J; Dept of Health, Education and Technology, Luleå University of Technology, Luleå, Sweden. |
| Abstrakt: |
Competing Interests: Conflict of interest: C. Stridsman has received personal fees from AstraZeneca, Boehringer Ingelheim and Novartis for lectures at sponsored meetings. L.E.G.W. Vanfleteren has received grants and personal fees from AstraZeneca and personal fees from GSK, Novartis, Boehringer Ingelheim, Menarini, Resmed, Chiesi, AGA Linde, Zambon and Pulmonx. J. Syk reports consulting fees paid to their employer from Orion Pharma. T. Sterner has received personal fees from ALK Abello for lectures at sponsored meetings. A. Lindberg has received personal fees from AstraZeneca, Novartis, Boehringer Ingelheim and GlaxoSmithKline for advisory boards and/or lectures at sponsored meetings. A. Tunsäter has received personal fees from AstraZeneca, Novartis, Boehringer Ingelheim and GlaxoSmithKline for advisory boards and/or lectures at sponsored meetings. F. Nyberg was an employee of AstraZeneca until 2019, and holds some AstraZeneca shares. J.R. Konradsen, S. Axelsson Fisk, C. Pedroletti, Y. Sjöö, A. Ekberg-Jansson and J. Karlsson Sundbaum have no conflicts of interest. |
